|
We asked 40 leaders, What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
| Improves the quality and number of innovative drugs available to patients |
19% |
| Restricts innovation and the development of new drugs |
51% |
| Has no impact on drug development |
1% |
| Don’t Know |
19% |
 |
|
|
|
|
|
|
|
3 June, 2014
|
|
|
India’s Renewed Pharma Market Potential
Recent changes in India’s population and economy have contributed to a shift in the country’s epidemiological profile towards ‘lifestyle’ diseases that are more prevalent in Western markets. Such changes have increased the demand for better healthcare and for medications that address chronic diseases...Read more |
Backlash as EU Blocks Further Limits to Human Embryo Research
Campaigners have been quick to respond to the rejection by the EU of a bid to impose additional limits on research involving human embryos, response, writes Peter O’Donnell ... Read more
|
Lack of Multichannel Confidence: A Step on the Road to Digital Maturity
It would be easy to see this year’s Across Health Multichannel Barometer survey results as further evidence that pharma is doomed to never get digital. But, writes Peter Houston, there is optimism that the results are a sign of the industry’s digital maturity ... Read more
|
Oncology Biomarker Testing: Why the UK Delay?
Amy Butcher investigates why the UK is lagging significantly behind Europe in the uptake of oncology biomarker testing — and looks at what the delays mean for pharma ... Read more
|
Pharma MBAs — From Mini Courses to the Full Monty
Over the past decade there has been a marked increase in the variety of specialist pharma MBA courses on offer. These courses last from one week in the case of most mini MBAs, up to a year’s full-time study or equivalent. Accordingly, the depth of learning provided by these different types of course varies enormously, writes John Ansell ... Read more
|
Product Cycle Strategies for Greater Profitability
In this compilation of four in-depth, data-rich reports from Pharmaceutical Executive, you'll learn a new set of metrics allowing companies to align their strategies around the push for greater profitability, putting them on the right track ... Click here to order.
|
|
|
|
|
